Delivery Order SPE2DR25D2006-SPE2DR26F55WK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,404.09 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $2,537.02 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,556.63 for Carvedilol ER 40 mg capsules (30-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,872.12 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on September 2, 2025, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $5,183.66 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) under a firm fixed-price contract valued at $6,954.24. This is a non-set-aside competitive award with an ultimate completion date of September 30, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,586.69 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, non-set-aside contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-day supply of Carvedilol ER 20 mg capsules, valued at $12,421.40 under a firm fixed price contract. The award, made on May 22, 2025, with an ultimate completion date of May 23, 2025, represents a non-set-aside competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $8,108.02. This firm fixed-price, competitively awarded delivery order represents a non-set-aside contract with an ultimate completion date of October 16, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,109.28 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 MG capsules (30-count units) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's significantly...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F55WKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,562.12 to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units). This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order with performance to be completed by November 4, 2025, at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains through competitively awarded delivery orders. This award for Carvedilol, a cardiovascular medication used in hypertension and heart failure management, exemplifies the routine pharmaceutical supply operations the contractor performs under its DLA prime vendor agreement, which enables it to supply medications and medical commodities to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 11/3/25 |